id stringlengths 11 11 | tags stringlengths 10 777 | text stringlengths 2 1.5k | dataset_num int64 1 3 | tokens list | ner_tags list |
|---|---|---|---|---|---|
NCT02390752 | 15:23:cancer,34:49:treatment,34:48:treatment,53:64:treatment,141:145:chronic_disease,,244:251:treatment | Patients with leukemia receiving corticosteroids or hydroxyurea are eligible provided that the corticosteroids are not being used to manage GVHD and there has been no increase in corticosteroid of hydroxyurea dose for 7 days prior to starting PLX3397 | 3 | [
"Patients",
"with",
"leukemia",
"receiving",
"corticosteroids",
"or",
"hydroxyurea",
"are",
"eligible",
"provided",
"that",
"the",
"corticosteroids",
"are",
"not",
"being",
"used",
"to",
"manage",
"GVHD",
"and",
"there",
"has",
"been",
"no",
"increase",
"in",
"c... | [
0,
0,
3,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02252081 | 1:28:chronic_disease | Decompensated heart failure | 3 | [
"Decompensated",
"heart",
"failure"
] | [
2,
2,
2
] |
NCT02141074 | 16:30:treatment | Any history of FIX inhibitors (defined by medical records) | 3 | [
"Any",
"history",
"of",
"FIX",
"inhibitors",
"(",
"defined",
"by",
"medical",
"records",
")"
] | [
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0
] |
NCT02446093 | ,8:18:treatment | >10 mg prednisone per day or equivalent | 3 | [
">",
"10",
"mg",
"prednisone",
"per",
"day",
"or",
"equivalent"
] | [
0,
0,
0,
1,
0,
0,
0,
0
] |
NCT03089905 | 39:50:treatment,,, | Planned future cumulative exposure to anaesthesia exceeding 2 hours before the age of 3 years | 3 | [
"Planned",
"future",
"cumulative",
"exposure",
"to",
"anaesthesia",
"exceeding",
"2",
"hours",
"before",
"the",
"age",
"of",
"3",
"years"
] | [
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02340156 | 1:25:treatment, | Prior focal radiotherapy within 3 months of screening | 3 | [
"Prior",
"focal",
"radiotherapy",
"within",
"3",
"months",
"of",
"screening"
] | [
1,
1,
1,
0,
0,
0,
0,
0
] |
NCT01950351 | 1:33:chronic_disease, | transmural myocardial infarction within the last 6 months | 3 | [
"transmural",
"myocardial",
"infarction",
"within",
"the",
"last",
"6",
"months"
] | [
2,
2,
2,
0,
0,
0,
0,
0
] |
NCT03101566 | 1:28:treatment, | Prior adjuvant chemotherapy is permitted provided it was completed > 6 months from registration | 3 | [
"Prior",
"adjuvant",
"chemotherapy",
"is",
"permitted",
"provided",
"it",
"was",
"completed",
">",
"6",
"months",
"from",
"registration"
] | [
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02076906 | 1:11:treatment,13:25:treatment,31:45:treatment | filgrastim, sargramostim, and erythropoietin | 3 | [
"filgrastim",
",",
"sargramostim",
",",
"and",
"erythropoietin"
] | [
1,
0,
1,
0,
0,
1
] |
NCT03095118 | 1:17:cancer | Multiple myeloma | 3 | [
"Multiple",
"myeloma"
] | [
3,
3
] |
NCT03060473 | 10:26:chronic_disease | Clinical chorioamnionitis | 3 | [
"Clinical",
"chorioamnionitis"
] | [
0,
2
] |
NCT02338999 | 14:16:chronic_disease | Diagnosis of DM or meeting DM criteria at screening visit, as established by new classification criteria | 3 | [
"Diagnosis",
"of",
"DM",
"or",
"meeting",
"DM",
"criteria",
"at",
"screening",
"visit",
",",
"as",
"established",
"by",
"new",
"classification",
"criteria"
] | [
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02367196 | 1:14:treatment, | Major surgery ≤ 2 weeks prior to starting CC-90002 | 3 | [
"Major",
"surgery",
"≤",
"2",
"weeks",
"prior",
"to",
"starting",
"CC-90002"
] | [
1,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT03048448 | 1:19:chronic_disease,27:44:chronic_disease,52:71:chronic_disease | Hepatic impairment due to non-liver disease (e.g., right heart failure) | 3 | [
"Hepatic",
"impairment",
"due",
"to",
"non-liver",
"disease",
"(",
"e.g.",
",",
"right",
"heart",
"failure",
")"
] | [
2,
2,
0,
0,
2,
2,
0,
0,
0,
2,
2,
2,
0
] |
NCT02931110 | 1:47:chronic_disease | 2nd-degree atrioventricular (AV) block type II | 3 | [
"2nd-degree",
"atrioventricular",
"(",
"AV",
")",
"block",
"type",
"II"
] | [
2,
2,
2,
2,
2,
2,
0,
0
] |
NCT02583893 | 22:35:cancer,53:75:cancer,89:96:treatment,102:111:treatment,115:127:treatment | Previously untreated secondary AML (from antecedent hematologic malignancy or following therapy with radiation or chemotherapy for another disease) with no evidence of favorable karyotype defined by presence of t(8;21)(q22;q22) [AML1-ETO], inv16(p13;q22), or t(16;16)(p13;q22) [CBFβ;MYH11] by cytogenetics, FISH, or RT-P... | 3 | [
"Previously",
"untreated",
"secondary",
"AML",
"(",
"from",
"antecedent",
"hematologic",
"malignancy",
"or",
"following",
"therapy",
"with",
"radiation",
"or",
"chemotherapy",
"for",
"another",
"disease",
")",
"with",
"no",
"evidence",
"of",
"favorable",
"karyotype"... | [
0,
0,
3,
3,
0,
0,
0,
3,
3,
0,
0,
1,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0... |
NCT02876302 | 1:23:chronic_disease | Erythema of the breast | 3 | [
"Erythema",
"of",
"the",
"breast"
] | [
2,
2,
2,
2
] |
NCT01453088 | 14:23:chronic_disease,25:30:chronic_disease,32:38:chronic_disease,42:62:chronic_disease | Uncontrolled bacterial, viral, fungal or parasitic infections | 3 | [
"Uncontrolled",
"bacterial",
",",
"viral",
",",
"fungal",
"or",
"parasitic",
"infections"
] | [
0,
2,
0,
2,
0,
2,
0,
2,
2
] |
NCT01184547 | 1:15:chronic_disease | Hyperlipidemia | 3 | [
"Hyperlipidemia"
] | [
2
] |
NCT00200889 | 1:22:chronic_disease | psychiatric disorders | 3 | [
"psychiatric",
"disorders"
] | [
2,
2
] |
NCT02180412 | 16:33:chronic_disease, | A diagnosis of diabetes mellitus, which might increase the risk of glucose infusion | 3 | [
"A",
"diagnosis",
"of",
"diabetes",
"mellitus",
",",
"which",
"might",
"increase",
"the",
"risk",
"of",
"glucose",
"infusion"
] | [
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02075671 | 12:44:chronic_disease | History of disorder of porphyrin metabolism | 3 | [
"History",
"of",
"disorder",
"of",
"porphyrin",
"metabolism"
] | [
0,
0,
2,
2,
2,
2
] |
NCT02562040 | 13:31:chronic_disease,41:44:treatment,56:93:chronic_disease,95:114:chronic_disease,116:152:chronic_disease,154:175:chronic_disease,180:201:chronic_disease | Significant cardiac arrhythmia noted on PSG including: non-sustained ventricular tachycardia, atrial fibrillation, second degree atrioventricular block, sustained bradycardia, or sustained tachycardia | 3 | [
"Significant",
"cardiac",
"arrhythmia",
"noted",
"on",
"PSG",
"including",
":",
"non-sustained",
"ventricular",
"tachycardia",
",",
"atrial",
"fibrillation",
",",
"second",
"degree",
"atrioventricular",
"block",
",",
"sustained",
"bradycardia",
",",
"or",
"sustained",... | [
0,
2,
2,
0,
0,
1,
0,
0,
2,
2,
2,
0,
2,
2,
0,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT01804634 | 7:26:chronic_disease | Major ABO incompatibility | 3 | [
"Major",
"ABO",
"incompatibility"
] | [
0,
2,
2
] |
NCT02310464 | 1:19:treatment,27:38:treatment,40:49:treatment,51:61:treatment,63:72:treatment,74:85:treatment,87:98:treatment | Immunosuppressants (e.g., cyclosporin, rapamycin, tacrolimus, rituximab, alemtuzumab, natalizumab, etc.) | 3 | [
"Immunosuppressants",
"(",
"e.g.",
",",
"cyclosporin",
",",
"rapamycin",
",",
"tacrolimus",
",",
"rituximab",
",",
"alemtuzumab",
",",
"natalizumab",
",",
"etc",
".",
")"
] | [
1,
0,
0,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
0,
0,
0
] |
NCT02076906 | 13:25:treatment | may receive transfusions | 3 | [
"may",
"receive",
"transfusions"
] | [
0,
0,
1
] |
NCT02004275 | 27:42:chronic_disease | Prior to study entry, any EKG abnormality at screening not felt to put the patient at risk has to be documented by the investigator as not medically significant | 3 | [
"Prior",
"to",
"study",
"entry",
",",
"any",
"EKG",
"abnormality",
"at",
"screening",
"not",
"felt",
"to",
"put",
"the",
"patient",
"at",
"risk",
"has",
"to",
"be",
"documented",
"by",
"the",
"investigator",
"as",
"not",
"medically",
"significant"
] | [
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02235857 | 1:18:chronic_disease, | Medical condition or disorder that would limit life expectancy to less than the primary clinical study endpoint or that may cause noncompliance with the study plan or confound the data analysis | 3 | [
"Medical",
"condition",
"or",
"disorder",
"that",
"would",
"limit",
"life",
"expectancy",
"to",
"less",
"than",
"the",
"primary",
"clinical",
"study",
"endpoint",
"or",
"that",
"may",
"cause",
"noncompliance",
"with",
"the",
"study",
"plan",
"or",
"confound",
... | [
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02911467 | 14:42:chronic_disease | Progressive, castration-resistant disease according to PCWG2 criteria | 3 | [
"Progressive",
",",
"castration-resistant",
"disease",
"according",
"to",
"PCWG2",
"criteria"
] | [
0,
0,
2,
2,
0,
0,
0,
0
] |
NCT02382549 | 42:54:treatment, | Participants who are currently receiving nitrosoureas or who have received this therapy 6 weeks prior to registration | 3 | [
"Participants",
"who",
"are",
"currently",
"receiving",
"nitrosoureas",
"or",
"who",
"have",
"received",
"this",
"therapy",
"6",
"weeks",
"prior",
"to",
"registration"
] | [
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01973283 | 1:26:chronic_disease,33:38:chronic_disease,40:46:chronic_disease,48:57:chronic_disease | End stage medical illness (e.g. liver, kidney, pulmonary) | 3 | [
"End",
"stage",
"medical",
"illness",
"(",
"e.g",
".",
"liver",
",",
"kidney",
",",
"pulmonary",
")"
] | [
2,
2,
2,
2,
0,
0,
0,
2,
0,
2,
0,
2,
0
] |
NCT03150004 | 18:33:treatment, | Participation in clinical trials with other investigational agents not included in this trial, within 14 days of the start of this trial and throughout the duration of this trial | 3 | [
"Participation",
"in",
"clinical",
"trials",
"with",
"other",
"investigational",
"agents",
"not",
"included",
"in",
"this",
"trial",
",",
"within",
"14",
"days",
"of",
"the",
"start",
"of",
"this",
"trial",
"and",
"throughout",
"the",
"duration",
"of",
"this",... | [
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01810588 | 22:34:cancer | accelerated phase or blast-crisis | 3 | [
"accelerated",
"phase",
"or",
"blast-crisis"
] | [
0,
0,
0,
3
] |
NCT03008616 | 1:16:chronic_disease | Pulmonary edema | 3 | [
"Pulmonary",
"edema"
] | [
2,
2
] |
NCT01686659 | 68:85:treatment | Any patients who cannot be transfused or has refused consent for a blood transfusion | 3 | [
"Any",
"patients",
"who",
"can",
"not",
"be",
"transfused",
"or",
"has",
"refused",
"consent",
"for",
"a",
"blood",
"transfusion"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT03021486 | 12:42:chronic_disease,46:69:chronic_disease,53:60:chronic_disease, | History of neuroleptic malignant syndrome or active seizure disorder (with seizure episode within the past week) | 3 | [
"History",
"of",
"neuroleptic",
"malignant",
"syndrome",
"or",
"active",
"seizure",
"disorder",
"(",
"with",
"seizure",
"episode",
"within",
"the",
"past",
"week",
")"
] | [
0,
0,
2,
2,
2,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01919619 | 1:22:chronic_disease, | myocardial infarction within 6 months of study entry | 3 | [
"myocardial",
"infarction",
"within",
"6",
"months",
"of",
"study",
"entry"
] | [
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT02064036 | ,41:52:treatment | within 30 days after discontinuation of finasteride | 3 | [
"within",
"30",
"days",
"after",
"discontinuation",
"of",
"finasteride"
] | [
0,
0,
0,
0,
0,
0,
1
] |
NCT02048371 | ,44:49:treatment,50:52:treatment,53:61:treatment | At least one site of measurable disease on x-ray/CT/MRI scan as defined by RECIST | 3 | [
"At",
"least",
"one",
"site",
"of",
"measurable",
"disease",
"on",
"x-ray/CT/MRI",
"scan",
"as",
"defined",
"by",
"RECIST"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0
] |
NCT02304458 | ,41:50:treatment,54:83:treatment,102:113:cancer | At least 21 days after the last dose of cytotoxic or myelosuppressive chemotherapy (42 days if prior nitrosourea) | 3 | [
"At",
"least",
"21",
"days",
"after",
"the",
"last",
"dose",
"of",
"cytotoxic",
"or",
"myelosuppressive",
"chemotherapy",
"(",
"42",
"days",
"if",
"prior",
"nitrosourea",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
1,
0,
0,
0,
0,
0,
3,
0
] |
NCT03101566 | 47:61:cancer,171:189:treatment,191:206:treatment,211:229:treatment | Patients must have a pathologically confirmed adenocarcinoma of the biliary tract (intra-hepatic, extra-hepatic (hilar, distal) or gall bladder) that is not eligible for curative resection, transplantation, or ablative therapies | 3 | [
"Patients",
"must",
"have",
"a",
"pathologically",
"confirmed",
"adenocarcinoma",
"of",
"the",
"biliary",
"tract",
"(",
"intra-hepatic",
",",
"extra-hepatic",
"(",
"hilar",
",",
"distal",
")",
"or",
"gall",
"bladder",
")",
"that",
"is",
"not",
"eligible",
"for... | [
0,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
1,
0,
0,
1,
1
] |
NCT02178566 | 8:26:chronic_disease, | Severe hepatic impairment (Child-Pugh Class C) | 3 | [
"Severe",
"hepatic",
"impairment",
"(",
"Child-Pugh",
"Class",
"C",
")"
] | [
0,
2,
2,
0,
0,
0,
0,
0
] |
NCT02474368 | ,,25:37:treatment | ≥10 mm and < 60 mm with neck CT scan | 3 | [
"≥10",
"mm",
"and",
"<",
"60",
"mm",
"with",
"neck",
"CT",
"scan"
] | [
0,
0,
0,
0,
0,
0,
0,
1,
1,
1
] |
NCT02460835 | 37:65:treatment | recovered from the acute effects of prior liver-directed therapy | 3 | [
"recovered",
"from",
"the",
"acute",
"effects",
"of",
"prior",
"liver-directed",
"therapy"
] | [
0,
0,
0,
0,
0,
0,
1,
1,
1
] |
NCT02856594 | 1:6:chronic_disease,11:24:chronic_disease,35:43:treatment,, | Renal and liver failure requiring dialysis or Child-Pugh score > 5 | 3 | [
"Renal",
"and",
"liver",
"failure",
"requiring",
"dialysis",
"or",
"Child-Pugh",
"score",
">",
"5"
] | [
2,
0,
2,
2,
0,
1,
0,
0,
0,
0,
0
] |
NCT03001830 | 1:20:chronic_disease | active tuberculosis | 3 | [
"active",
"tuberculosis"
] | [
2,
2
] |
NCT03044821 | 1:4:chronic_disease | MMC with the upper boundary located between T1 and S1 | 3 | [
"MMC",
"with",
"the",
"upper",
"boundary",
"located",
"between",
"T1",
"and",
"S1"
] | [
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02424968 | 1:11:treatment, | prednisone at a physiologic dose of 5 mg per day or less is allowed | 3 | [
"prednisone",
"at",
"a",
"physiologic",
"dose",
"of",
"5",
"mg",
"per",
"day",
"or",
"less",
"is",
"allowed"
] | [
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02321501 | 65:86:chronic_disease,90:115:chronic_disease,140:151:chronic_disease,153:181:chronic_disease,183:205:chronic_disease,207:233:chronic_disease,262:283:chronic_disease,340:364:treatment | Patients with known history of extensive disseminated bilateral interstitial fibrosis or interstitial lung disease, including a history of pneumonitis, hypersensitivity pneumonitis, interstitial pneumonia, obliterative bronchiolitis, and clinically significant radiation pneumonitis (i.e. affecting activities of daily l... | 3 | [
"Patients",
"with",
"known",
"history",
"of",
"extensive",
"disseminated",
"bilateral",
"interstitial",
"fibrosis",
"or",
"interstitial",
"lung",
"disease",
",",
"including",
"a",
"history",
"of",
"pneumonitis",
",",
"hypersensitivity",
"pneumonitis",
",",
"interstiti... | [
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
2,
2,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0
] |
NCT02530463 | 1:58:treatment | Prior treatment with allogeneic stem cell transplantation | 3 | [
"Prior",
"treatment",
"with",
"allogeneic",
"stem",
"cell",
"transplantation"
] | [
1,
1,
1,
1,
1,
1,
1
] |
NCT02903446 | 1:66:treatment | Treatment history with pegloticase or another recombinant uricase | 3 | [
"Treatment",
"history",
"with",
"pegloticase",
"or",
"another",
"recombinant",
"uricase"
] | [
1,
1,
1,
1,
1,
1,
1,
1
] |
NCT03133013 | 24:35:chronic_disease | atients with suspected sleep apnea, based on symptoms | 3 | [
"atients",
"with",
"suspected",
"sleep",
"apnea",
",",
"based",
"on",
"symptoms"
] | [
0,
0,
0,
2,
2,
0,
0,
0,
0
] |
NCT02101853 | 93:120:treatment,144:163:chronic_disease,165:173:chronic_disease,175:193:chronic_disease,195:217:chronic_disease,219:228:chronic_disease,230:242:chronic_disease,243:260:chronic_disease,265:283:chronic_disease | Patients with pre-existing significant central nervous system pathology that would preclude treatment with blinatumomab, including: history of severe brain injury, dementia, cerebellar disease, organic brain syndrome, psychosis, coordination/movement disorder, or autoimmune disease with CNS involvement | 3 | [
"Patients",
"with",
"pre-existing",
"significant",
"central",
"nervous",
"system",
"pathology",
"that",
"would",
"preclude",
"treatment",
"with",
"blinatumomab",
",",
"including",
":",
"history",
"of",
"severe",
"brain",
"injury",
",",
"dementia",
",",
"cerebellar",... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
2,
2,
2,
0,
2,
0,
2,
2,
0,
2,
2,
2,
0,
2,
0,
2,
2,
0,
0,
2,
2,
0,
0,
0
] |
NCT01970176 | 20:44:chronic_disease,, | Prior diagnosis of intrinsic renal diseases including renal artery stenosis of > 50% | 3 | [
"Prior",
"diagnosis",
"of",
"intrinsic",
"renal",
"diseases",
"including",
"renal",
"artery",
"stenosis",
"of",
">",
"50",
"%"
] | [
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02616185 | 93:105:treatment,107:118:treatment,124:156:cancer | For post-secondary hormone patients, no concurrent treatment with a secondary hormone (e.g. enzalutamide, abiraterone), no metastasis to the liver or brain | 3 | [
"For",
"post-secondary",
"hormone",
"patients",
",",
"no",
"concurrent",
"treatment",
"with",
"a",
"secondary",
"hormone",
"(",
"e.g",
".",
"enzalutamide",
",",
"abiraterone",
")",
",",
"no",
"metastasis",
"to",
"the",
"liver",
"or",
"brain"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
0,
0,
3,
3,
3,
3,
3,
3
] |
NCT02053909 | 22:51:treatment,57:65:treatment,67:77:treatment,81:92:treatment,94:110:treatment,112:139:chronic_disease,141:144:chronic_disease,145:147:chronic_disease | Anticipated need for postoperative anticoagulation with coumadin, dabigatran or rivaroxaban (mechanical valve, chronic atrial fibrillation, DVT/PE) | 3 | [
"Anticipated",
"need",
"for",
"postoperative",
"anticoagulation",
"with",
"coumadin",
",",
"dabigatran",
"or",
"rivaroxaban",
"(",
"mechanical",
"valve",
",",
"chronic",
"atrial",
"fibrillation",
",",
"DVT/PE",
")"
] | [
0,
0,
0,
1,
1,
0,
1,
0,
1,
0,
1,
0,
1,
1,
0,
2,
2,
2,
0,
2,
0
] |
NCT01614197 | 1:15:treatment,54:80:treatment,92:99:treatment,101:129:treatment | Anticoagulants: Patients who are currently receiving therapeutic anticoagulants (including aspirin, low molecular weight heparin, and others) are not eligible | 3 | [
"Anticoagulants",
":",
"Patients",
"who",
"are",
"currently",
"receiving",
"therapeutic",
"anticoagulants",
"(",
"including",
"aspirin",
",",
"low",
"molecular",
"weight",
"heparin",
",",
"and",
"others",
")",
"are",
"not",
"eligible"
] | [
1,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
1,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT02592473 | 69:80:allergy_name | Hypersensitivity reactions to contrast material not manageable with prophylaxis | 3 | [
"Hypersensitivity",
"reactions",
"to",
"contrast",
"material",
"not",
"manageable",
"with",
"prophylaxis"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
4
] |
NCT02642939 | 37:61:treatment,66:105:chronic_disease,112:129:treatment,136:157:treatment | Patients who require treatment with systemic corticosteroids for serious medical conditions or illnesses (e.g. immunosuppression after organ transplantation) | 3 | [
"Patients",
"who",
"require",
"treatment",
"with",
"systemic",
"corticosteroids",
"for",
"serious",
"medical",
"conditions",
"or",
"illnesses",
"(",
"e.g",
".",
"immunosuppression",
"after",
"organ",
"transplantation",
")"
] | [
0,
0,
0,
0,
0,
1,
1,
0,
2,
2,
2,
2,
2,
0,
0,
0,
1,
0,
1,
1,
0
] |
NCT02311361 | 40:64:treatment,,92:104:treatment,109:127:treatment | Patients should not be vaccinated with live attenuated vaccines within 1 month of starting Tremelimumab and MEDI4736 treatment | 3 | [
"Patients",
"should",
"not",
"be",
"vaccinated",
"with",
"live",
"attenuated",
"vaccines",
"within",
"1",
"month",
"of",
"starting",
"Tremelimumab",
"and",
"MEDI4736",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
1,
0,
1,
1
] |
NCT02267772 | ,,,,119:137:chronic_disease,139:153:chronic_disease,155:167:chronic_disease,169:182:chronic_disease,184:199:chronic_disease,203:211:chronic_disease,235:244:treatment,250:272:treatment,307:324:treatment | pregnant women greater than 16 weeks of pregnancy who present with pain due to a maternal medical condition including sickle cell crisis, pyelonephritis, pancreatitis, cholecystitis, nephrolithiasis or headache and who are warranting treatment with intravenous medication for pain control as part of their routine treatm... | 3 | [
"pregnant",
"women",
"greater",
"than",
"16",
"weeks",
"of",
"pregnancy",
"who",
"present",
"with",
"pain",
"due",
"to",
"a",
"maternal",
"medical",
"condition",
"including",
"sickle",
"cell",
"crisis",
",",
"pyelonephritis",
",",
"pancreatitis",
",",
"cholecyst... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
0,
2,
0,
2,
0,
2,
0,
2,
0,
2,
0,
0,
0,
0,
1,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02120222 | 1:21:chronic_disease | Symptomatic ischemia | 3 | [
"Symptomatic",
"ischemia"
] | [
2,
2
] |
NCT02561988 | 1:25:cancer | Mast cell leukemia (MCL) | 3 | [
"Mast",
"cell",
"leukemia",
"(",
"MCL",
")"
] | [
3,
3,
3,
3,
0,
0
] |
NCT02479698 | 27:36:chronic_disease,40:46:treatment,54:66:chronic_disease,,103:111:chronic_disease,119:140:chronic_disease | Patients with microscopic hematuria OR biopsy proven BK nephritis and urine or blood PCR positive for BK virus and/or JC viral encephalitis | 3 | [
"Patients",
"with",
"microscopic",
"hematuria",
"OR",
"biopsy",
"proven",
"BK",
"nephritis",
"and",
"urine",
"or",
"blood",
"PCR",
"positive",
"for",
"BK",
"virus",
"and/or",
"JC",
"viral",
"encephalitis"
] | [
0,
0,
0,
2,
0,
1,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2
] |
NCT00788164 | 1:10:chronic_disease | Psoriasis | 3 | [
"Psoriasis"
] | [
2
] |
NCT03081390 | 16:27:treatment | Treatment with antibiotics | 3 | [
"Treatment",
"with",
"antibiotics"
] | [
0,
0,
1
] |
NCT01877382 | 32:59:treatment,95:103:chronic_disease | Has unresolved toxicities from previous anticancer therapy, defined as toxicities (other than alopecia) not yet resolved to NCI-CTCAE v4 | 3 | [
"Has",
"unresolved",
"toxicities",
"from",
"previous",
"anticancer",
"therapy",
",",
"defined",
"as",
"toxicities",
"(",
"other",
"than",
"alopecia",
")",
"not",
"yet",
"resolved",
"to",
"NCI-CTCAE",
"v4"
] | [
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT02920788 | 108:111:allergy_name | other reasons for being unable or unwilling to participate in study procedures (e.g., contraindications to MRI) | 3 | [
"other",
"reasons",
"for",
"being",
"unable",
"or",
"unwilling",
"to",
"participate",
"in",
"study",
"procedures",
"(",
"e.g.",
",",
"contraindications",
"to",
"MRI",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
4,
0
] |
NCT02553642 | 13:23:cancer,,106:112:cancer,153:168:treatment,189:198:treatment | Other prior malignancy active within the previous 2 years except for local or organ confined early stage cancer that has been definitively treated with curative intent or does not require treatment, does not require ongoing treatment, has no evidence of active disease and has a negligible risk of recurrence and is ther... | 3 | [
"Other",
"prior",
"malignancy",
"active",
"within",
"the",
"previous",
"2",
"years",
"except",
"for",
"local",
"or",
"organ",
"confined",
"early",
"stage",
"cancer",
"that",
"has",
"been",
"definitively",
"treated",
"with",
"curative",
"intent",
"or",
"does",
... | [
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01175044 | 15:40:chronic_disease,50:53:chronic_disease,54:58:chronic_disease | Patients with chronic immunosuppression (such as HIV/AIDS) | 3 | [
"Patients",
"with",
"chronic",
"immunosuppression",
"(",
"such",
"as",
"HIV/AIDS",
")"
] | [
0,
0,
2,
2,
0,
0,
0,
2,
0
] |
NCT03067129 | 31:45:chronic_disease | Participants with other known liver diseases | 3 | [
"Participants",
"with",
"other",
"known",
"liver",
"diseases"
] | [
0,
0,
0,
0,
2,
2
] |
NCT00368355 | ,,80:88:cancer | Patients with a life expectancy (< / = 6 weeks) limited by diseases other than leukemia | 3 | [
"Patients",
"with",
"a",
"life",
"expectancy",
"(",
"<",
"/",
"=",
"6",
"weeks",
")",
"limited",
"by",
"diseases",
"other",
"than",
"leukemia"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3
] |
NCT02560766 | 1:26:chronic_disease,,, | Uncontrolled hypertension defined as blood pressure (BP) ≥ 95 percentile adjusted for age, height, and sex, according to the tables published by the US Department of Health and Human Services 2005, at screening and before dosing | 3 | [
"Uncontrolled",
"hypertension",
"defined",
"as",
"blood",
"pressure",
"(",
"BP",
")",
"≥",
"95",
"percentile",
"adjusted",
"for",
"age",
",",
"height",
",",
"and",
"sex",
",",
"according",
"to",
"the",
"tables",
"published",
"by",
"the",
"US",
"Department",
... | [
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03114891 | 1:4:allergy_name | MRI contraindications | 3 | [
"MRI",
"contraindications"
] | [
4,
0
] |
NCT02565498 | 1:7:cancer | Benign histology | 3 | [
"Benign",
"histology"
] | [
3,
0
] |
NCT01372631 | 23:44:treatment | Patients undergoing a reduction mammoplasty | 3 | [
"Patients",
"undergoing",
"a",
"reduction",
"mammoplasty"
] | [
0,
0,
0,
1,
1
] |
NCT02178566 | 55:64:treatment,134:150:chronic_disease,164:191:chronic_disease,223:242:chronic_disease | Any known factor or disease that might interfere with treatment compliance, study conduct or interpretation of the results including musculo-skeletal limitations, peripheral arterial disease, drug or alcohol dependence or psychiatric disease | 3 | [
"Any",
"known",
"factor",
"or",
"disease",
"that",
"might",
"interfere",
"with",
"treatment",
"compliance",
",",
"study",
"conduct",
"or",
"interpretation",
"of",
"the",
"results",
"including",
"musculo-skeletal",
"limitations",
",",
"peripheral",
"arterial",
"disea... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
2,
2
] |
NCT02208362 | 85:98:treatment | Research participants being treated for severe infection or who are recovering from major surgery | 3 | [
"Research",
"participants",
"being",
"treated",
"for",
"severe",
"infection",
"or",
"who",
"are",
"recovering",
"from",
"major",
"surgery"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02516696 | 26:28:cancer,116:128:cancer,132:151:treatment | Subject has immeasurable MM (no measurable monoclonal protein, free light chains in blood or urine, or measureable plasmacytoma on radiologic scanning) | 3 | [
"Subject",
"has",
"immeasurable",
"MM",
"(",
"no",
"measurable",
"monoclonal",
"protein",
",",
"free",
"light",
"chains",
"in",
"blood",
"or",
"urine",
",",
"or",
"measureable",
"plasmacytoma",
"on",
"radiologic",
"scanning",
")"
] | [
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
1,
1,
0
] |
NCT02479906 | 26:41:treatment | Subject has a history of cranial surgery | 3 | [
"Subject",
"has",
"a",
"history",
"of",
"cranial",
"surgery"
] | [
0,
0,
0,
0,
0,
1,
1
] |
NCT02312596 | 16:19:chronic_disease | Wagner 3, 4, 5 DFU | 3 | [
"Wagner",
"3",
",",
"4",
",",
"5",
"DFU"
] | [
0,
0,
0,
0,
0,
0,
2
] |
NCT02369900 | 30:37:treatment,52:58:chronic_disease,59:63:chronic_disease | Known allergy/sensitivity to esmolol or history of asthma/COPD | 3 | [
"Known",
"allergy/sensitivity",
"to",
"esmolol",
"or",
"history",
"of",
"asthma/COPD"
] | [
0,
0,
0,
1,
0,
0,
0,
2
] |
NCT02138617 | 13:29:chronic_disease,37:52:treatment,64:79:treatment,101:120:chronic_disease,,156:163:treatment,166:177:treatment | Significant vascular disease (e.g., aortic aneurysm, requiring surgical repair or recent peripheral arterial thrombosis) within 6 months prior to Day 1 of FOLFIRI + bevacizumab initiation | 3 | [
"Significant",
"vascular",
"disease",
"(",
"e.g.",
",",
"aortic",
"aneurysm",
",",
"requiring",
"surgical",
"repair",
"or",
"recent",
"peripheral",
"arterial",
"thrombosis",
")",
"within",
"6",
"months",
"prior",
"to",
"Day",
"1",
"of",
"FOLFIRI",
"+",
"bevaci... | [
0,
2,
2,
0,
0,
0,
1,
1,
0,
0,
1,
1,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0
] |
NCT02392572 | ,,,151:161:treatment | Sexually active men must also use acceptable contraceptive methods for the duration of time on study and for at least 16 weeks after the last dose of study drug | 3 | [
"Sexually",
"active",
"men",
"must",
"also",
"use",
"acceptable",
"contraceptive",
"methods",
"for",
"the",
"duration",
"of",
"time",
"on",
"study",
"and",
"for",
"at",
"least",
"16",
"weeks",
"after",
"the",
"last",
"dose",
"of",
"study",
"drug"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01037790 | 1:18:chronic_disease | diabetes mellitus | 3 | [
"diabetes",
"mellitus"
] | [
2,
2
] |
NCT02535312 | 23:35:treatment,39:51:treatment,,,80:92:treatment,96:107:treatment, | Patients who have had chemotherapy or radiotherapy within 4 weeks (6 weeks for nitrosoureas or mitomycin C) prior to entering the study or those who have not recovered from adverse events due to agents administered more than 4 weeks earlier | 3 | [
"Patients",
"who",
"have",
"had",
"chemotherapy",
"or",
"radiotherapy",
"within",
"4",
"weeks",
"(",
"6",
"weeks",
"for",
"nitrosoureas",
"or",
"mitomycin",
"C",
")",
"prior",
"to",
"entering",
"the",
"study",
"or",
"those",
"who",
"have",
"not",
"recovered"... | [
0,
0,
0,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02501733 | 30:49:chronic_disease | Patients with a diagnosis of osteoarthritis (OA) | 3 | [
"Patients",
"with",
"a",
"diagnosis",
"of",
"osteoarthritis",
"(",
"OA",
")"
] | [
0,
0,
0,
0,
0,
2,
2,
0,
0
] |
NCT00720785 | 1:26:cancer | pancreas (adenocarcinoma) | 3 | [
"pancreas",
"(",
"adenocarcinoma",
")"
] | [
3,
3,
0,
0
] |
NCT02881242 | 35:75:chronic_disease | New York Heart Association (NYHA) class III or IV congestive heart failure | 3 | [
"New",
"York",
"Heart",
"Association",
"(",
"NYHA",
")",
"class",
"III",
"or",
"IV",
"congestive",
"heart",
"failure"
] | [
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
2,
2,
2,
2
] |
NCT01726257 | 22:38:chronic_disease | Ruptured, leaking or mycotic aneurysm | 3 | [
"Ruptured",
",",
"leaking",
"or",
"mycotic",
"aneurysm"
] | [
0,
0,
0,
0,
2,
2
] |
NCT02403128 | 13:26:chronic_disease, | Symptomatic macular edema caused by RAM in one of the eyes | 3 | [
"Symptomatic",
"macular",
"edema",
"caused",
"by",
"RAM",
"in",
"one",
"of",
"the",
"eyes"
] | [
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02573246 | 15:32:treatment | Subjects with cochlear implants | 3 | [
"Subjects",
"with",
"cochlear",
"implants"
] | [
0,
0,
1,
1
] |
NCT03056287 | 1:19:chronic_disease, | attempt of suicide in the last 2 years | 3 | [
"attempt",
"of",
"suicide",
"in",
"the",
"last",
"2",
"years"
] | [
2,
2,
2,
0,
0,
0,
0,
0
] |
NCT02178709 | ,,22:34:treatment | Hemoglobin ≥ 9 g/dL (transfusions are acceptable) | 3 | [
"Hemoglobin",
"≥",
"9",
"g/dL",
"(",
"transfusions",
"are",
"acceptable",
")"
] | [
0,
0,
0,
0,
0,
1,
0,
0,
0
] |
NCT01505062 | 25:45:chronic_disease,130:137:treatment,228:236:chronic_disease,238:275:chronic_disease,290:297:chronic_disease,299:320:chronic_disease,322:350:chronic_disease | Presence of significant ocular abnormalities in the study eye that in the opinion of the investigator would preclude the planned surgery, effective safety follow-up, or interfere with the interpretation of study endpoints (eg, glaucoma, corneal or significant lens opacities, pre-existing uveitis, intraocular infection,... | 3 | [
"Presence",
"of",
"significant",
"ocular",
"abnormalities",
"in",
"the",
"study",
"eye",
"that",
"in",
"the",
"opinion",
"of",
"the",
"investigator",
"would",
"preclude",
"the",
"planned",
"surgery",
",",
"effective",
"safety",
"follow-up",
",",
"or",
"interfere... | [
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
2,
2,
2,
2,
2,
0,
0,
2,
0,
2,
2,
0,
2,
2,
0
] |
NCT02397083 | 1:29:treatment | Prior progesterone treatment | 3 | [
"Prior",
"progesterone",
"treatment"
] | [
1,
1,
1
] |
NCT02273375 | 31:40:chronic_disease,48:86:chronic_disease,99:130:chronic_disease,132:147:chronic_disease,149:173:chronic_disease,175:196:chronic_disease,225:256:chronic_disease,267:277:treatment,,,308:335:chronic_disease | Patients who have experienced untreated and/or uncontrolled cardiovascular conditions and/or have symptomatic cardiac dysfunction (unstable angina, congestive heart failure, myocardial infarction within the previous year or cardiac ventricular arrhythmias requiring medication, history of 2nd or 3rd degree atrioventricu... | 3 | [
"Patients",
"who",
"have",
"experienced",
"untreated",
"and/or",
"uncontrolled",
"cardiovascular",
"conditions",
"and/or",
"have",
"symptomatic",
"cardiac",
"dysfunction",
"(",
"unstable",
"angina",
",",
"congestive",
"heart",
"failure",
",",
"myocardial",
"infarction",... | [
0,
0,
0,
0,
2,
0,
2,
2,
2,
0,
0,
2,
2,
2,
2,
2,
2,
0,
2,
2,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0
] |
NCT03131037 | 8:32:treatment,,41:51:treatment,84:116:treatment | Use of systemic corticosteroids (>10 mg prednisone per day or equivalent) or other systemic immunosuppressive drugs | 3 | [
"Use",
"of",
"systemic",
"corticosteroids",
"(",
">",
"10",
"mg",
"prednisone",
"per",
"day",
"or",
"equivalent",
")",
"or",
"other",
"systemic",
"immunosuppressive",
"drugs"
] | [
0,
0,
1,
1,
1,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03151434 | 15:19:treatment | Pt undergoing VATS procedure at Indiana University Hospital | 3 | [
"Pt",
"undergoing",
"VATS",
"procedure",
"at",
"Indiana",
"University",
"Hospital"
] | [
0,
0,
1,
0,
0,
0,
0,
0
] |
NCT02004275 | 10:26:chronic_disease | Adequate cardiac function | 3 | [
"Adequate",
"cardiac",
"function"
] | [
0,
2,
2
] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.